Z Zimmer Biomet Holdings, Inc.
| Market Cap | $18.01B |
| P/E Ratio | 25.60 |
| Forward P/E | 10.11 |
| Dividend Yield | 1.06% |
| Beta | 0.61 |
| 52W Range | $85.48 - $111.49 |
| # Hedge Funds | 9 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 10 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Hillman Value Fund Hillman Capital Management | 2.60% | $4.13M | 45,969 | Reduce 12.96% |
| Harry Burn Sound Shore Management | 2.43% | $76.50M | 850,757 | Reduce 5.08% |
| Robert Olstein Olstein Capital Management | 1.61% | $7.00K | 82,000 | Add 5.13% |
| Bill Nygren Harris Associates LP | 1.39% | $1.10B | 12,264,703 | Add 158.17% |
| Dodge & Cox Dodge & Cox | 1.14% | $2.11B | 23,506,849 | Add 1.25% |
| Sarah Ketterer Causeway Capital Management | 0.90% | $65.51M | 728,498 | Add 25.22% |
| David Katz Matrix Asset Advisors | 0.24% | $2.70M | 30,032 | Reduce 75.02% |
| Mairs & Power Growth Fund Mairs & Power Inc | 0.01% | $998.00K | 11,100 | Reduce 20.46% |
| Charles Bobrinskoy Ariel Investments | 0.00% | $289.00K | 3,229 | Reduce 99.18% |
| First Eagle Investment Management First Eagle Investment Management | 0.00% | $0 | 0 | Sold |
Insider Trading
| Insider Name of the company insider who made the trade 2 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Winkler LoriSVP and CHRO | Sale | 2,650 | $94.66 | $250.85K | 12 Mar 2026 | 12 Mar 2026 |
| Yi SangGroup President, Asia Pacific | Sale | 1,000 | $96.49 | $96.49K | 12 Feb 2026 | 17 Feb 2026 |
Frequently Asked Questions
What is ZBH stock price today?
Zimmer Biomet Holdings, Inc. (ZBH) is currently trading at $90.89. The stock has a 52-week range of $85.48 to $111.49 and a market capitalization of $18.01B.
Is ZBH a good stock to buy in 2026?
Zimmer Biomet Holdings, Inc. has a P/E ratio of 25.6 (forward P/E: 10.1), a dividend yield of 1.06%, and 1-year performance of -18.5%. 10 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ZBH stock?
There have been 2 insider transactions for ZBH in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ZBH stock performed over the past year?
Zimmer Biomet Holdings, Inc. (ZBH) has returned -18.5% over the past 12 months. The stock traded between $85.48 and $111.49 during this period, and is currently at $90.89.
Which hedge funds own ZBH (Zimmer Biomet Holdings, Inc.)?
10 tracked hedge funds currently hold ZBH in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ZBH's market cap and valuation?
Zimmer Biomet Holdings, Inc. (ZBH) has a market capitalization of $18.01B. The trailing P/E ratio is 25.6 and forward P/E is 10.1. The stock is classified in the Healthcare sector.
What is ZBH's revenue and profitability?
Zimmer Biomet Holdings, Inc. reported revenue of $8.23B with net income of $705.10M and a profit margin of 0.09%. The stock has a beta of 0.61.
What sector is ZBH in and who are its biggest institutional holders?
Zimmer Biomet Holdings, Inc. (ZBH) operates in the Healthcare sector. It is held by 10 tracked hedge funds. See the ownership table above for the complete list.